Mei Pharma Stock Price Prediction
| MEIP Stock | USD 2.85 0.05 1.79% |
Oversold Vs Overbought
59
Oversold | Overbought |
Wall Street Target Price 20 | Quarterly Revenue Growth (1.00) |
Using MEI Pharma hype-based prediction, you can estimate the value of MEI Pharma from the perspective of MEI Pharma response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards MEI Pharma using MEI Pharma's stock options and short interest. It helps to benchmark the overall future attitude of investors towards MEI using crowd psychology based on the activity and movement of MEI Pharma's stock price.
MEI Pharma Implied Volatility | 4.8 |
MEI Pharma's implied volatility exposes the market's sentiment of MEI Pharma stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if MEI Pharma's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that MEI Pharma stock will not fluctuate a lot when MEI Pharma's options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in MEI Pharma to buy its stock at a price that has no basis in reality. In that case, they are not buying MEI because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
MEI Pharma after-hype prediction price | USD 2.85 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current MEI contract
Based on the Rule 16, the options market is currently suggesting that MEI Pharma will have an average daily up or down price movement of about 0.3% per day over the life of the 2025-03-21 option contract. With MEI Pharma trading at USD 2.85, that is roughly USD 0.00855 . If you think that the market is fully incorporating MEI Pharma's daily price movement you should consider acquiring MEI Pharma options at the current volatility level of 4.8%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
MEI |
MEI Pharma After-Hype Price Prediction Density Analysis
As far as predicting the price of MEI Pharma at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in MEI Pharma or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of MEI Pharma, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
MEI Pharma Estimiated After-Hype Price Volatility
In the context of predicting MEI Pharma's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on MEI Pharma's historical news coverage. MEI Pharma's after-hype downside and upside margins for the prediction period are 0.73 and 4.97, respectively. We have considered MEI Pharma's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
MEI Pharma is somewhat reliable at this time. Analysis and calculation of next after-hype price of MEI Pharma is based on 3 months time horizon.
MEI Pharma Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as MEI Pharma is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading MEI Pharma backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with MEI Pharma, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.10 | 2.12 | 0.00 | 0.04 | 3 Events / Month | 14 Events / Month | In about 3 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
2.85 | 2.85 | 0.00 |
|
MEI Pharma Hype Timeline
MEI Pharma is now traded for 2.85. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.04. MEI is forecasted not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is forecasted to be very small, whereas the daily expected return is now at -0.1%. %. The volatility of related hype on MEI Pharma is about 532.54%, with the expected price after the next announcement by competition of 2.81. About 41.0% of the company shares are owned by institutional investors. The company has price-to-book ratio of 0.77. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. MEI Pharma recorded a loss per share of 6.99. The entity last dividend was issued on the 16th of November 2023. The firm had 1:20 split on the 17th of April 2023. Given the investment horizon of 90 days the next forecasted press release will be in about 3 days. Check out MEI Pharma Basic Forecasting Models to cross-verify your projections.MEI Pharma Related Hype Analysis
Having access to credible news sources related to MEI Pharma's direct competition is more important than ever and may enhance your ability to predict MEI Pharma's future price movements. Getting to know how MEI Pharma's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how MEI Pharma may potentially react to the hype associated with one of its peers.
MEI Pharma Additional Predictive Modules
Most predictive techniques to examine MEI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for MEI using various technical indicators. When you analyze MEI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About MEI Pharma Predictive Indicators
The successful prediction of MEI Pharma stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as MEI Pharma, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of MEI Pharma based on analysis of MEI Pharma hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to MEI Pharma's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to MEI Pharma's related companies. | 2024 | 2025 (projected) | Dividend Yield | 0.55 | 0.49 | Price To Sales Ratio | 0.33 | 0.32 |
Story Coverage note for MEI Pharma
The number of cover stories for MEI Pharma depends on current market conditions and MEI Pharma's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that MEI Pharma is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about MEI Pharma's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
MEI Pharma Short Properties
MEI Pharma's future price predictability will typically decrease when MEI Pharma's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of MEI Pharma often depends not only on the future outlook of the potential MEI Pharma's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. MEI Pharma's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.7 M | |
| Dividends Paid | 11.7 M | |
| Cash And Short Term Investments | 38.3 M | |
| Shares Float | 4.9 M |
Additional Tools for MEI Stock Analysis
When running MEI Pharma's price analysis, check to measure MEI Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MEI Pharma is operating at the current time. Most of MEI Pharma's value examination focuses on studying past and present price action to predict the probability of MEI Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MEI Pharma's price. Additionally, you may evaluate how the addition of MEI Pharma to your portfolios can decrease your overall portfolio volatility.